Psychedelic Stock Picker

Click the button below to randomly select 5 psychedelic stocks from a list of 20. These stocks are related to psychedelic medicine and MDMA research. This is not financial advice. Please do your own due diligence before investing your money into these psychedelic stocks.

Pick 5 Stocks

What Each Company Does

If you’re curious about the companies inside the PSYK ETF, you’re in the right place. I’ve been following these companies closely, and each one is doing something unique in the psychedelic medicine space. Let’s break it down.

Compass Pathways (Most popular Psychedelic Stock)

Compass Pathways is a leader in psilocybin therapy. They’re focused on treating severe depression, especially in patients who haven’t responded to other treatments. Their research is groundbreaking, and they’ve already made significant progress in clinical trials.

MindMed

MindMed is exploring the use of psychedelics like LSD and MDMA for mental health conditions. They’re working on treatments for anxiety, ADHD, and even addiction. I’ve been impressed by their innovative approach and the potential of their therapies.

Atai Life Sciences

Atai Life Sciences is a biotech company with a broad focus on mental health. They’re developing treatments using various psychedelics, including psilocybin and DMT. With backing from big names like Peter Thiel, they’re one of the most promising players in the field [[2]].

Cybin

Cybin is another key player in the psychedelic space. They’re developing psychedelic-based therapies for mental health disorders, including depression and anxiety. Their focus on creating new, patentable compounds sets them apart from the competition.

Field Trip Health

Field Trip Health is unique because they’re not just developing treatments—they’re also running clinics where patients can receive psychedelic-assisted therapy. They’re making these treatments more accessible, which is a big step forward for mental health care.

Numinus Wellness

Numinus Wellness is focused on both research and treatment. They’re conducting clinical trials and also offering psychedelic-assisted therapy in their clinics. Their holistic approach to mental health is something I find particularly exciting.

Revive Therapeutics

Revive Therapeutics is working on psychedelic treatments, but they’re also exploring other areas like cannabinoids and rare diseases. Their diverse portfolio makes them an interesting player in the biotech space.

Do your own Research!

Each of these companies is pushing the boundaries of mental health treatment. Whether it’s through psilocybin, LSD, or other psychedelics, they’re all working towards the same goal: better mental health for everyone. By investing in PSYK, you’re supporting their efforts and helping to bring these treatments to the people who need them most.